Severe Hepatotoxicity Due to Osimertinib After Nivolumab Therapy in Patients With Non‐small Cell Lung Cancer Harboring EGFR Mutation
Thoracic Cancer - Australia
doi 10.1111/1759-7714.13363
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2020
Authors
Publisher
Wiley